[European drug policy: welcomed modernization but shortage of political proposals concerning industry and research].
Alván
Gunnar
G
Gunnar.Alvan@mpa.se
D002986:Clinical Trials as Topic / Q000191:economics; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence* / Q000639:trends; D004346:Drug Information Services / Q000331:legislation & jurisprudence; D011307:Drug Prescriptions / Q000191:economics; D016568:Drugs, Generic / Q000191:economics; D004465:Economic Competition; D005062:European Union; D006291:Health Policy / Q000191:economics / Q000331:legislation & jurisprudence* / Q000639:trends; D006801:Humans; D007391:International Cooperation; D040541:Marketing; D004366:Nonprescription Drugs / Q000191:economics; D011057:Politics; D012106:Research / Q000191:economics / Q000639:trends; D012922:Social Change
D016568:Drugs, Generic; D004366:Nonprescription Drugs